Cardiac Amyloidosis

Cardiac Amyloidosis

Cardiac Amyloidosis

Course Director(s): Martha Grogan, M.D.

Released On: March 15, 2014 - Length: 42:41

Overview

slide

Cardiac amyloidosis is an important cause of restrictive cardiomyopathy and is not as rare as previously reported. Transthyretin cardiac amyloidosis is an under-recognized cause of heart failure in middle-aged and elderly men and in blacks. Treatment is now available for all types of cardiac amyloidosis and is rapidly evolving. Delayed diagnosis continues to be a major determinant of poor prognosis. This tutorial will review the three most types of amyloid that involve the heart. The state-of-the art approach to diagnosis and management of cardiac amyloidosis will be discussed.

Objectives

  • Recognize the types of amyloid that affect the heart and the clinical characteristics of each type
  • Summarize the appropriate diagnostic evaluation for suspected cardiac amyloidosis
  • Demonstrate an understanding of the treatment options for patients with cardiac amyloidosis

Faculty


Martha Grogan, M.D., FACC

Assistant Professor of Medicine
Director Cardiac Amyloid Clinic
Division of Cardiovascular Disease and Internal Medicine
Mayo Clinic, Rochester, MN

Pricing

$40 - Streaming Video

$50 - Streaming Video and DVD


Recently Viewed

slide

Product Coming Soon

$40-$50

 
Date: 3/15/2014 - 3/15/2018

Back to top